Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07422012 · ClinicalTrials.gov registry record
Tacrolimus in Pregnancy
A clinical trial, sponsored by Baylor Research Institute.
- Not yet
- Registry status
- 55
- Enrollment target
NCT07422012 is a clinical trial that has not yet begun recruiting, run by Baylor Research Institute. The registered enrollment target is 55 participants.
The verdict
NCT07422012 has not yet begun recruiting, sponsored by Baylor Research Institute.
- NOT YET RECRUITING
- Registry status
- 55 participants
- Enrollment target
Study Summary
To create a formula that adjusts tacrolimus blood levels. This is needed because pregnant patients have higher levels of unbound tacrolimus. The adjusted formula will give a more accurate measure of the active drug in pregnant uterus transplant patients.
Interventions
- BIOLOGICAL Modeling of unbound and whole blood tacrolimus in pregnant uterus transplant recipients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2026-05-31 |
| Est. Completion | 2028-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07422012
The ClinicalTrials.gov registry entry for NCT07422012 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Modeling of unbound and whole blood tacrolimus in pregnant uterus transplant recipients is the first listed.
NCT07422012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07422012 about?
NCT07422012 is a clinical study titled "Tacrolimus in Pregnancy". To create a formula that adjusts tacrolimus blood levels. This is needed because pregnant patients have higher levels of unbound tacrolimus. The adjusted formula will give a more accurate measure of the active drug in pregnant uterus transplant patients.
What is the current status of trial NCT07422012?
This trial is currently not yet recruiting. The enrollment target is 55 participants. The study started on 2026-05-31. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07422012?
The interventions under investigation include: Modeling of unbound and whole blood tacrolimus in pregnant uterus transplant recipients (BIOLOGICAL).
Who is sponsoring clinical trial NCT07422012?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.